- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LivaNova PLC (LIVN)LivaNova PLC stock price live, this page displays NASDAQ LIVN stock exchange data. View the LIVN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LivaNova PLC real time stock price chart below.
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 52.50.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 52.50.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
52.50
+0.02(+0.04%)
Closed
Pre Market
53.26+0.76(+1.45%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
52.10
53.35
52 wk Range
42.75
64.47
LIVN Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
52.1053.35
52 wk Range
42.7564.47
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockLIVN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
69.00
Upside
+31.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
LivaNova PLC Company Profile
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
LivaNova PLC SWOT Analysis
VNS Therapy Potential | LivaNova's Vagus Nerve Stimulation Therapy shows promise for epilepsy treatment and explores applications in treatment-resistant depression, awaiting RECOVER study results. |
Financial Outlook | Analysts project EPS of $2.98 for FY2024 and $3.19 for FY2025, with an average price target of $61, reflecting cautious optimism amid mixed top-line results. |
Market Positioning | Delve into LivaNova's strategy to maintain its $2.86B market cap in the competitive U.S. Medical Supplies & Devices sector, leveraging technological advancements. |
Growth Challenges | Explore LivaNova's navigation of regulatory hurdles, market acceptance issues, and resource allocation dilemmas as it seeks to expand its product portfolio. |
LIVN Full Pro Research
Institutional-Grade Stock Analysis
Understand how LIVN earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
LivaNova PLC Earnings Call Summary for Q4/2024
- LivaNova reports 11% Q3 revenue growth, raises 2024 outlook to 8.5%-9.5% revenue growth and $3.30-$3.40 adjusted EPS
- Cardiopulmonary revenue up 15%, epilepsy revenue up 9%; Essenz heart-lung machine contributes 400 basis points to growth
- Adjusted operating income for ACS segment rises to $64M from $45M; adjusted free cash flow increases to $47M from $26M
- Company expects 10% manufacturing output increase from late 2023 to late 2024, aims for 100% Essenz system penetration in 3 years
- LivaNova anticipates margin growth to outpace revenue in 2025, with EPS growth projected above 20% for 2024
Last Updated: 31-10-2024, 05:02 pm
Read Full TranscriptCompare LIVN to Peers and Sector
Metrics to compare | LIVN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIVNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 120.4x | −2.9x | −0.7x | |
PEG Ratio | 0.16 | 0.07 | 0.00 | |
Price/Book | 2.2x | 3.1x | 2.6x | |
Price / LTM Sales | 2.3x | 4.7x | 3.2x | |
Upside (Analyst Target) | 33.3% | 29.7% | 40.8% | |
Fair Value Upside | Unlock | 1.3% | 5.7% | Unlock |
Analysts' Recommendations
8 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 69.00
(+31.43% Upside)
FAQ
What Is the LivaNova PLC (LIVN) Stock Price Today?
The LivaNova PLC stock price today is 52.50.
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Is the LivaNova PLC Market Cap?
As of today, LivaNova PLC market cap is 2.85B.
What is LivaNova PLC Earnings Per Share?
The LivaNova PLC EPS is 0.437.
What Is the Next LivaNova PLC Earnings Date?
LivaNova PLC will release its next earnings report on 18 Feb 2025.
From a Technical Analysis Perspective, Is LIVN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.